HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.
Ranjan Ramasamy, Speaker at Immunology Conferences
Keynote Presentation
Ranjan Ramasamy, IDFISH Technology, United States

Lyme disease (LD) is caused by certain species of tick-borne bacteria of the genus Borrelia termed Lyme disease Borreliae (LDB). LD often causes chronic debilitating infections that are difficult to diagnose by clinical symptoms alone. The detection of serum antibodies to specifi [....] » Read More

Zhaohua Zhou, Speaker at Immunology Conferences
Keynote Presentation
Zhaohua Zhou, Food and Drug Administration, United States

Polyethylene glycol (PEG)- modification (PEGylation) is a highly successful strategy for improving the therapeutic properties of protein products. PEGylation increases protein size, inhibits proteolysis and decreases renal filtration, thereby improving the pharmacokinetics (half- [....] » Read More

Ranjan Ramasamy, Speaker at Immunology Conferences
Keynote Presentation
Ranjan Ramasamy, IDFISH Technology, United States

The nasal epithelium is the initial site of SARS-CoV-2 infection. Early and effective immune responses in the upper respiratory tract (URT) can limit and eliminate the infection in the URT, thereby preventing infection of the lower respiratory tract and the development of severe [....] » Read More

WenQing Yang, Speaker at Immunology Conferences
Keynote Presentation
WenQing Yang, Founder/Chief Scientific Officer, ClinBridge Biotech Corp., China

With the revolutionary progress of cancer immunotherapy, more clinically relevant preclinical animal models are needed to support the efficacy assessment, MOA elucidation and translational research for immune-oncology (I/O) drugs. Humanized murine models have been developed to st [....] » Read More

Roque Gabriel Wiseman Pinto, Speaker at Immunology Conferences
Oral Presentation
Roque Gabriel Wiseman Pinto, Medical College, India

COVID – 19 (SARS – CoV-2) Severe Acute Respiratory Corona Virus, has caused a pandemic world wide and changed the Health Care and the Disease profile scenario world wide. The effects are due to the  COVID 19 Disease  Vaccination Long COVID &ndash [....] » Read More

Esin Kirikkaya, Speaker at Clinical Immunology conference
Oral Presentation
Esin Kirikkaya, Health Sciences University İzmir Tepecik Training and Research Hospital, Turkey

Purpose: To evaluate the effect of subcutaneous omalizumab therapy on the allergic conjunctivitis symptoms of patients being treated for asthma. Methods: A total of 84 eyes of 42 patients who were receiving subcutaneous omalizumab therapy for asthma and complained of a [....] » Read More

Maliheh Amani, Speaker at Clinical immunology conference
Oral Presentation
Maliheh Amani, Department of Dermatology, Gonabad University of Medical Sciences, Iran (Islamic Republic of)

Introduction: Scarring alopecia (cicatricial alopecia) refers to disorders that are characterized by the irreversible destruction of hair follicles and permanent alopecia. Scarring alopecia is categorized into primary and secondary. Primary scarring alopecia (cicatricial alo [....] » Read More

Juan Huang, Speaker at Immunology conferences
Oral Presentation
Juan Huang, Yale University, United States

Objective: Increasing evidence supports the observation that IgA exerts a critical effect on the susceptibility to autoimmunity by modulating gut homeostasis and subsequent host immunity. We hypothesized that the IgA immunity is altered in individuals with type 1 diabetes. [....] » Read More

Marina Awad Zaher, Speaker at Immunology Conference
Oral Presentation
Marina Awad Zaher, Beni-Suef University, Egypt

Background: Much concern was directed towards studying cardiovascular dysfunction in patients with multiple sclerosis (MS). However, the mechanisms of such dysfunction are not completely elucidated.  Aim of the work: The aim of our work was to assess cardiac and arterial [....] » Read More

Gholamreza Anani Sarab, Speaker at Immunology Conference
Oral Presentation
Gholamreza Anani Sarab, Birjand University of Medical Sciences, Iran (Islamic Republic of)

Background: Multiple Sclerosis (MS) is a chronic neurodegenerative disease of the central nervous system. The main feature of this disease is the formation of inflammatory lesions in the white matter of the brain and spinal cord due to inappropriate immune responses against the m [....] » Read More

Luca Roncati, Speaker at Immunology Conference
Oral Presentation
Luca Roncati, University of Modena and Reggio Emilia, Italy

Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT), also known as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) or vaccine-associated thrombotic thrombocytopenia (VATT) or thrombosis with thrombocytopenia syndrome (TTS), is a rare potentially lethal blood c [....] » Read More

Xuexiang Du, Speaker at Immunology Conference
Oral Presentation
Xuexiang Du, Shandong University School of Basic Medical Sciences, China

Cancer immunotherapy is becoming a powerful and acceptable treatment to malignant tumor in addition to traditional methods such as surgery, radiotherapy and chemotherapy. Anti-CTLA-4 monoclonal antibodies confer a cancer immunotherapeutic effect (CITE) but cause severe immunother [....] » Read More

Bushra Akhtar, Speaker at Immunology Conference
Oral Presentation
Bushra Akhtar, University of Agriculture, Pakistan

Rheumatoid arthritis (RA) is a chronic autoimmune disease and is characterized by inflammation, tissue damage and functional impairment. Methotrexate (MTX) is used in treatment of RA but numerous adverse effects are associated with its use. It has fast clearance as well. These fa [....] » Read More

Amal Saad Hussein, Speaker at Immunology Conference
Oral Presentation
Amal Saad Hussein, Environment & Climate Change Research Institute, National Research Centre, Egypt

Immune disturbances are described among wide variety of occupational exposures to chemical, biological or physical pollutants. Several studies have shown that occupational chronic exposure to pesticides, mycotoxins, organic solvents, dyes, heavy metals; such as mercury, cadmium, [....] » Read More

Miceska Simona, Speaker at Immunology Conference
Oral Presentation
Miceska Simona, Institute of Oncology Ljubljana, Slovenia

Background: High-grade serous carcinoma (HGSC) is the most common and aggressive type of ovarian cancer, and is often associated with ascites at presentation. Our objective was to evaluate the accuracy of cytopathology to identify immunophenotypic features of HGSC and BRCA1/2 mut [....] » Read More

Alec Bigness, Speaker at Clinical Immunology Conferences
Poster Presentation
Alec Bigness, University of South Florida Morsani College of Medicine, United States

Introduction Highly active antiretroviral therapy (HAART) has substantially reduced the prevalence of Kaposi Sarcoma (KS),1,2 yet its effectivity has rendered a new phenomenon, KS-IRIS, a serious condition where patients experience paradoxical worsening after HAART initiation th [....] » Read More

Laura Elisa Buitrago Molina, Speaker at Immunology Conferences
Poster Presentation
Laura Elisa Buitrago Molina, Hannover Medical School, Germany

Autoimmune hepatitis (AIH) is a chronic autoimmune inflammatory disease that usually requires life-long immunosuppression. Frequent relapses after discontinuation of therapy indicate that intrahepatic immune regulation is not restored by current therapies. As steroid therapy pref [....] » Read More

Ismail Osmanov, Speaker at Covid-19 Global Conference
Keynote Presentation
Ismail Osmanov, Children's city clinical hospital, Russian Federation

Virus-neutralizing monoclonal antibodies (mAbs) are designed to create a passive or enhance the natural immune response against a foreign agent. For the first time, the introduction of monoclonal antibodies to children for the treatment of new coronavirus infection (hereinafter r [....] » Read More

WenQing Yang, Speaker at Immunology Conferences
Keynote Presentation
WenQing Yang, Founder/Chief Scientific Officer, ClinBridge Biotech Corp., China

Multiple sclerosis (MS) is one of the most common causes of neurological dysfunction representing unmet medical need, which demands novel therapies toward a cure. Experimental autoimmune encephalomyelitis (EAE) is the most commonly used model for studying autoimmune-mediated myel [....] » Read More

Matthias Hardtke Wolenski, Speaker at Immunology Conferences
Oral Presentation
Matthias Hardtke Wolenski, Hannover Medical School, Germany

Adoptive immunotherapy with ex vivo expanded, polyspecific regulatory T cells (Tregs) is a promising treatment for graft-versus-host disease. Animal transplantation models used by us and others have demonstrated that the adoptive transfer of allospecific Tregs offers greater prot [....] » Read More

Lissete Sanchez Magraner, Speaker at Immunotherapies Congress
Oral Presentation
Lissete Sanchez Magraner, Hawk Biosystems, Spain

Non–small cell lung carcinoma (NSCLC) is known to evade host immune defenses via a downregulation of the immune response. One of the molecules involved in this mechanism is programmed cell death ligand 1 (PD-L1), which interacts with its receptor, programmed cell death prot [....] » Read More

Watsapp